Moreover, it has been reported that the IL-17A_rs8193036 and IL-17A haplotypes are significantly associated with the risk of central obesity, hypertriglyceridemia, and metabolic syndrome in MM patients with premature coronary artery disease [36]; nonetheless, we did not observe LD for these variants in our sample. Here, IL17A is linked to metabolic syndrome.